首页> 外文期刊>Journal of minimally invasive gynecology >Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer
【24h】

Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer

机译:前哨淋巴结映射与吲哚菁绿近红外荧光成像:子宫内膜和宫颈癌患者腹腔镜平台的新工具。

获取原文
获取原文并翻译 | 示例
       

摘要

Indocyanine green (ICG) represents a feasible alternative to the more traditional methods of sentinel lymph node (SLN) mapping, and interest in this promising tracer is growing. This report outlines our experience with ICG in a minimally invasive laparoscopic approach in women with endometrial cancer and cervical cancer using the Storz SPIES ICG near-infrared fluorescence imaging technology. A total of 49 patients with clinical stage I endometrial cancer (n = 40) or stage I cervical cancer (n = 9) were retrospectively reviewed. All patients had undergone simple or radical laparoscopic hysterectomy with pelvic and/or aortic lymphadenectomy and SLN mapping by means of an intracervical injection of ICG dye at the 3 o'clock and 9 o'clock locations after the induction of general anesthesia. The detection rate of ICG was 100% (49 of 49). The rate of bilateral SLN detection was 86% (42 of 49). Positive lymph nodes were found in 6 patients (12%), with at least 1 positive SLN. The sensitivity and negative predictive value of SLN detection were 100%. All procedures were successfully completed without conversion to open laparotomy, and no intraoperative or postoperative complications occurred. In our preliminary experience, ICG showed a high overall detection rate, and bilateral mapping appears to be a feasible alternative to the more traditional methods of SLN mapping in patients with endometrial cancer and cervical cancer. Laparoscopic SLN mapping with ICG appears to be safe, easy, and reproducible, with a positive impact on patient management. (C) 2016 AAGL. All rights reserved.
机译:吲哚菁绿(ICG)代表了较传统的前哨淋巴结(SLN)映射方法的可行替代方案,并且对该前途示踪剂的兴趣正在增长。本报告概述了我们使用Storz SPIES ICG近红外荧光成像技术以微创腹腔镜方法治疗子宫内膜癌和宫颈癌女性的经验。回顾性分析了49例临床I期子宫内膜癌(n = 40)或I期宫颈癌(n = 9)患者。所有患者均在全身麻醉诱导后3点和9点通过腹腔注射ICG染料进行了简单或根治性腹腔镜子宫切除术及盆腔和/或主动脉淋巴结清扫术和SLN标测。 ICG的检测率为100%(49个中的49个)。双边SLN检出率为86%(49中的42)。 6名患者(12%)发现淋巴结阳性,SLN至少阳性。 SLN检测的灵敏度和阴性预测值为100%。所有手术均成功完成,无需转换为开放式剖腹手术,且未发生术中或术后并发症。根据我们的初步经验,ICG在子宫内膜癌和宫颈癌患者中显示出较高的整体检测率,并且双边映射似乎是更传统的SLN映射方法的可行替代方案。腹腔镜SLN与ICG的映射似乎是安全,容易且可重现的,对患者管理产生了积极影响。 (C)2016 AAGL。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号